Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity
Almost everyone can have non-surgical skin tightening & firming treatments for their chest at our offices because we have a large variety of lasers and other technology available
The difference between pulling 1 unit and 2 units is a 100% dosing error, and at that scale, the margin for mistake is unacceptably thin
Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease
In 2024, both Novo Nordisk and Eli Lilly said that they were not supplying compounders with the semaglutide and tirzepatide they are selling to their customers